Integrative Analysis of GWAS and Transcriptomics Data Reveal Key Genes for Non-small Lung Cancer

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2023 Aug 17

PMID 37592093

Authors

Xiangxiong Feng

Affiliations

Soon will be listed here.

Abstract

Lung cancer is one of the world's most common and deadly cancers. The two main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). More than 85% of lung cancers are NSCLC. Genetic factors play a significant role in the risk of NSCLC. Growing studies focus on studying risk factors at the molecular level. The aim of the study is to build a pipeline to integrate Genome-wide association analysis (GWAS) and transcriptomics data with machine learning to effectively identify genetic risk factors of NSCLC. GWAS datasets and GWAS summary data were downloaded from GWAS catalog, which include lung carcinoma genetic variants among the European population. Then, with the GWAS summary, data functional analysis of significant SNPs was performed using a webserver called FUMAGWAS. The transcriptomics data of NSCLC and non-NSCLC people were used to build a machine learning model to identify the key genes that help predict the NSCLC. The top up-regulation and down-regulation genes were identified by the BART cancer webserver, and the mechanistic roles of the genes were validated by literature review. By performing integrative analysis of GWAS and transcriptomics analysis using machine learning, we identified multiple SNPs and genes that related to NSCLC. The computational pipeline may facilitate the biomarker discovery for NSCLC and other diseases.

References

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Oser M, Niederst M, Sequist L, Engelman J . Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015; 16(4):e165-72. PMC: 4470698. DOI: 10.1016/S1470-2045(14)71180-5. View

Skrickova J, Kadlec B, Venclicek O, Merta Z . Lung cancer. Cas Lek Cesk. 2018; 157(5):226-236. View

Webb J, Burns R, Brown H, LeRoy B, Kosarek C . Squamous cell carcinoma. Compend Contin Educ Vet. 2009; 31(3):E9. View

Ettinger D, Akerley W, Borghaei H, Chang A, Cheney R, Chirieac L . Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013; 11(6):645-53. DOI: 10.6004/jnccn.2013.0084. View

Sinha R, Kulldorff M, Curtin J, Brown C, Alavanja M, Swanson C . Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control. 1999; 9(6):621-30. DOI: 10.1023/a:1008805525525. View

Bade B, Dela Cruz C . Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020; 41(1):1-24. DOI: 10.1016/j.ccm.2019.10.001. View

10.

Loeb L, Ernster V, Warner K, Abbotts J, Laszlo J . Smoking and lung cancer: an overview. Cancer Res. 1984; 44(12 Pt 1):5940-58. View

11.

Tammemagi M, Berg C, Riley T, Cunningham C, Taylor K . Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014; 106(6):dju084. PMC: 4081623. DOI: 10.1093/jnci/dju084. View

12.

DOLL R, Peto R, Boreham J, Sutherland I . Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005; 92(3):426-9. PMC: 2362086. DOI: 10.1038/sj.bjc.6602359. View

13.

Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P . Risk factors for lung cancer worldwide. Eur Respir J. 2016; 48(3):889-902. DOI: 10.1183/13993003.00359-2016. View

14.

Lorenzo-Gonzalez M, Torres-Duran M, Barbosa-Lorenzo R, Provencio-Pulla M, Barros-Dios J, Ruano-Ravina A . Radon exposure: a major cause of lung cancer. Expert Rev Respir Med. 2019; 13(9):839-850. DOI: 10.1080/17476348.2019.1645599. View

15.

Lee S, Cheah Y . The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression. J Immunol Res. 2019; 2019:3046379. PMC: 6421779. DOI: 10.1155/2019/3046379. View

16.

Altorki N, Markowitz G, Gao D, Port J, Saxena A, Stiles B . The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2018; 19(1):9-31. PMC: 6749995. DOI: 10.1038/s41568-018-0081-9. View

17.

Hsieh C, Hsieh H, Shih F, Wang P, Yang L, Shieh D . An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics. 2021; 11(14):7072-7091. PMC: 8171079. DOI: 10.7150/thno.57803. View

18.

Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S . A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene. 2021; 40(26):4413-4424. DOI: 10.1038/s41388-021-01853-y. View

19.

Dai J, Lv J, Zhu M, Wang Y, Qin N, Ma H . Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019; 7(10):881-891. PMC: 7015703. DOI: 10.1016/S2213-2600(19)30144-4. View

20.

Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z . A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011; 43(8):792-6. DOI: 10.1038/ng.875. View